C. Friese

SATB1 in Malignant T Cells.

J. Becker, C. Geisler, M. Wasik, 2018, The Journal of investigative dermatology.

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

I. Svane, Ö. Met, M. Carretta, 2022, Oncoimmunology.

Inflammation induced PD-L1-specific T cells

Ö. Met, P. Straten, C. Bonefeld, 2019, Cell stress.

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

G. Coukos, M. Donia, I. Svane, 2019, British Journal of Cancer.

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

I. Svane, H. Hasselbalch, Ö. Met, 2018, Leukemia.

CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer

M. Donia, K. Harbst, I. Svane, 2020, Scientific Reports.

Neutropenia‐related aspergillosis in non‐transplant haematological patients hospitalised under ambient air versus purified air conditions

A. Hüttmann, U. Dührsen, L. Eisele, 2023, Mycoses.

Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

M. Donia, I. Svane, S. Hadrup, 2023, Frontiers in Immunology.